Viewing StudyNCT00113256



Ignite Creation Date: 2024-05-05 @ 11:42 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00113256
Status: TERMINATED
Last Update Posted: 2013-01-23
First Post: 2005-06-06

Brief Title: Orathecin Gemcitabine Versus Placebo Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer
Sponsor: Astex Pharmaceuticals Inc
Organization: Astex Pharmaceuticals Inc

Conditions & Keywords Data

Conditions:
Name
Pancreatic Cancer
Keywords:
Name View
rubitecan View
Orathecin View
9-nitrocamptothecin View
gemcitabine View
Gemzar View
pancreatic cancer View
adenocarcinoma View
RFS 2000 View